Evidence map›Paper›PMID 35958144›Full record

ArticleFrontiers in microbiology2022

Evidence of recurrent selection of mutations commonly found in SARS-CoV-2 variants of concern in viruses infecting immunocompromised patients.

Livia R Goes, Juliana D Siqueira, Marianne M Garrido, Brunna M Alves, Claudia Cicala, James Arthos, João P B Viola, Marcelo A Soares

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Livia R GoesOncovirology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Juliana D SiqueiraOncovirology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Marianne M GarridoHospital Infection Control Committee, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Brunna M AlvesOncovirology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Claudia CicalaLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States.
James ArthosLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States.
João P B ViolaImmunology and Tumor Biology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Marcelo A SoaresOncovirology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Instituto Nacional do Câncer · BRNational Institute of Allergy and Infectious Diseases · USHospital do Câncer III · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronically immunosuppressed patients infected with SARS-CoV-2 often experience prolonged virus shedding, and may pave the way to the emergence of mutations that render viral variants of concern (VOC) able to escape immune responses induced by natural infection or by vaccination. We report herein a SARS-CoV-2

Indexed as

deletions/mutationsimmunocompromised patientlong term virus sheddingNsp6SARS-CoV2 infectionspikeVOC

Identifiers

PMID35958144
PMCPMC9362983
OpenAlexW4287921650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.